El viernes 27, Hadrián Álvarez Fernández (Grupo Nucleósidos) presentará su trabajo "Allosteric Inhibition of Neutral Sphingomyelinase 2 (nSMase2) by DPTIP: From Antiflaviviral Activity to Deciphering Its Binding Site through In Silico Studies and Experimental Validation"